 possibl influenc antibiot result bacillu calmette-guerin intraves therapi superfici bladder cancer intraves treatment bacillu calmette-guerin establish treatment carcinoma situ effect prophylaxi prevent recurr transit cell carcinoma instil therapi oral antibiot urinari tract infect tuberculostat agent local irrit symptom system side effect bacillu calmette-guerin suscept differ bacillu calmette-guerin prepar antibiot tuberculostat agent vitro prepar suscept commonli antibiot tuberculostat agent except pyrazinamid result absenc cystiti instil antibiot possibl inhibit antitumor efficaci erad bacillu calmette-guerin organ inhibit tuberculostat agent local system complic bacillu calmette-guerin instil therapi